Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Preferred Stock [Member] Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock, Common [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2022	$ 2,695	$ 6	$ 216,195	$ (228,169)	$ (408)	$ 20,615	$ 10,934
Balance, shares at Dec. 31, 2022	1,205,759	6,300,703
Balance at Mar. 31, 2023	$ 2,767	$ 7	221,341	(246,172)		32,861	10,804
Balance, shares at Mar. 31, 2023	1,229,887	6,706,427
Balance at Dec. 31, 2022	$ 2,695	$ 6	216,195	(228,169)	(408)	20,615	10,934
Balance, shares at Dec. 31, 2022	1,205,759	6,300,703
Dividends declared - Series B Convertible Preferred Stock	$ 146			(146)
Dividends declared - Series B Convertible Preferred Stock, shares	48,738
Issue common stock - PAVM ATM Facility			1,166				1,166
Issue common stock - PAVM ATM Facility, shares		155,384
Vest - restricted stock awards
Vest - restricted stock awards, shares		6,666
Conversions - Senior Secured Convertible Note		$ 1	4,422				4,423
Conversions - Senior Secured Convertible Note, shares		634,899
Impact of subsidiary equity transactions			1,332			(1,332)
Issuance - vendor service agreement			600			147	747
Issuance - vendor service agreement, shares		100,000
Stock-based compensation - PAVmed Inc.			2,288				2,288
Stock-based compensation - subsidiaries			646			3,992	4,638
Net Loss				(32,468)		(7,638)	(40,106)
Purchase - Employee Stock Purchase Plan			122		60		182
Purchase - Employee Stock Purchase Plan, shares		25,626
Purchase - subsidiary common stock - Employee Stock Purchase Plan						276	276
Issuance - subsidiary common stock - Committed Equity Facility, net of financing charges						284	284
Issuance - subsidiary common stock - Settlement APA-RDx - Installment Payment						713	713
Issuance - subsidiary preferred stock (Series A)						13,625	13,625
Treasury stock			(348)		348
Treasury stock, shares		12,589
Balance at Jun. 30, 2023	$ 2,841	$ 7	226,423	(260,783)		30,682	(830)
Balance, shares at Jun. 30, 2023	1,254,497	7,235,867
Balance at Dec. 31, 2022	$ 2,695	$ 6	216,195	(228,169)	(408)	20,615	10,934
Balance, shares at Dec. 31, 2022	1,205,759	6,300,703
Balance at Dec. 31, 2023	$ 2,993	$ 9	237,600	(294,433)		29,813	(24,018)
Balance, shares at Dec. 31, 2023	1,305,213	8,578,505
Balance at Mar. 31, 2023	$ 2,767	$ 7	221,341	(246,172)		32,861	10,804
Balance, shares at Mar. 31, 2023	1,229,887	6,706,427
Dividends declared - Series B Convertible Preferred Stock	$ 74			(74)
Dividends declared - Series B Convertible Preferred Stock, shares	24,610
Issue common stock - PAVM ATM Facility			609				609
Issue common stock - PAVM ATM Facility, shares		83,250
Conversions - Senior Secured Convertible Note			2,395				2,395
Conversions - Senior Secured Convertible Note, shares		346,190
Impact of subsidiary equity transactions			143			(143)
Issuance - vendor service agreement			600			147	747
Issuance - vendor service agreement, shares		100,000
Stock-based compensation - PAVmed Inc.			1,090				1,090
Stock-based compensation - subsidiaries			245			1,172	1,417
Net Loss				(14,537)		(3,355)	(17,892)
Balance at Jun. 30, 2023	$ 2,841	$ 7	226,423	(260,783)		30,682	(830)
Balance, shares at Jun. 30, 2023	1,254,497	7,235,867
Balance at Dec. 31, 2023	$ 2,993	$ 9	237,600	(294,433)		29,813	(24,018)
Balance, shares at Dec. 31, 2023	1,305,213	8,578,505
Balance at Mar. 31, 2024	$ 3,071	$ 9	237,863	(309,723)		48,205	(20,575)
Balance, shares at Mar. 31, 2024	1,331,336	8,858,597
Balance at Dec. 31, 2023	$ 2,993	$ 9	237,600	(294,433)		29,813	(24,018)
Balance, shares at Dec. 31, 2023	1,305,213	8,578,505
Dividends declared - Series B Convertible Preferred Stock	$ 158			(158)
Dividends declared - Series B Convertible Preferred Stock, shares	52,763
Issue common stock - PAVM ATM Facility			693				693
Issue common stock - PAVM ATM Facility, shares		333,299
Vest - restricted stock awards
Vest - restricted stock awards, shares		4,064
Conversions - Senior Secured Convertible Note		$ 1	1,112				1,113
Conversions - Senior Secured Convertible Note, shares		574,424
Conversions - subsidiary common stock - Senior Secured Convertible Note						2,541	2,541
Impact of subsidiary equity transactions			2,169			(2,169)
Issuance - vendor service agreement			50			401	451
Issuance - vendor service agreement, shares		29,757
Stock-based compensation - PAVmed Inc.			1,532				1,532
Stock-based compensation - subsidiaries			306			1,948	2,254
Net Loss				(26,039)		(7,387)	(33,426)
Exercise - stock options of subsidiary						4	4
Purchase - Employee Stock Purchase Plan			62				62
Purchase - Employee Stock Purchase Plan, shares		34,332
Purchase - subsidiary common stock - Employee Stock Purchase Plan						353	353
Issuance - subsidiary preferred stock (Series A-1)						5,670	5,670
Exchange - subsidiary preferred stock (Series A and Series A-1)						(24,294)	(24,294)
Issuance - subsidiary preferred stock (Series B and Series B-1)						55,919	55,919
Subsidiary deemed dividends on preferred stock attributable to noncontrolling interests						(7,496)	(7,496)
Balance at Jun. 30, 2024	$ 3,151	$ 10	243,524	(320,630)		55,303	(18,642)
Balance, shares at Jun. 30, 2024	1,357,976	9,554,381
Balance at Mar. 31, 2024	$ 3,071	$ 9	237,863	(309,723)		48,205	(20,575)
Balance, shares at Mar. 31, 2024	1,331,336	8,858,597
Dividends declared - Series B Convertible Preferred Stock	$ 80			(80)
Dividends declared - Series B Convertible Preferred Stock, shares	26,640
Issue common stock - PAVM ATM Facility			198				198
Issue common stock - PAVM ATM Facility, shares		200,000
Vest - restricted stock awards
Vest - restricted stock awards, shares		4,064
Conversions - Senior Secured Convertible Note		$ 1	805				806
Conversions - Senior Secured Convertible Note, shares		461,963
Conversions - subsidiary common stock - Senior Secured Convertible Note						1,854	1,854
Impact of subsidiary equity transactions			3,903			(3,903)
Issuance - vendor service agreement			50			401	451
Issuance - vendor service agreement, shares		29,757
Issuance - subsidiary preferred stock (Series B-1)						11,634	11,634
Stock-based compensation - PAVmed Inc.			598				598
Stock-based compensation - subsidiaries			107			1,199	1,306
Net Loss				(10,827)		(4,087)	(14,914)
Balance at Jun. 30, 2024	$ 3,151	$ 10	$ 243,524	$ (320,630)		$ 55,303	$ (18,642)
Balance, shares at Jun. 30, 2024	1,357,976	9,554,381